SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-14-144186
Filing Date
2014-04-15
Accepted
2014-04-15 16:11:54
Documents
11
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10K d650079d10k.htm 10-K 681855
2 CERTIFICATION d650079dex311.htm EX-31.1 8329
3 CERTIFICATION d650079dex312.htm EX-31.2 8165
4 CERTIFICATION d650079dex321.htm EX-32.1 3103
5 CERTIFICATION d650079dex322.htm EX-32.2 3110
  Complete submission text file 0001193125-14-144186.txt   3385579

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT hppi-20131231.xml EX-101.INS 301840
7 XBRL TAXONOMY EXTENSION SCHEMA hppi-20131231.xsd EX-101.SCH 43923
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hppi-20131231_cal.xml EX-101.CAL 41609
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hppi-20131231_def.xml EX-101.DEF 121416
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE hppi-20131231_lab.xml EX-101.LAB 308862
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hppi-20131231_pre.xml EX-101.PRE 201009
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-13467 | Film No.: 14765143
SIC: 8731 Services-Commercial Physical & Biological Research